Rasan (8313) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
9 Dec, 2025Executive summary
Achieved strong revenue growth of 40% year-over-year to SAR 358M, with EBITDA up 78% and net profit up 106% to SAR 95M for FY 2024.
Expanded product portfolio, including new lines in health, financial services, and value-added services.
Enhanced operational efficiency and customer experience through digital innovation and automation.
Financial highlights
Revenue reached SAR 358M, up 40% year-over-year; gross margin improved by 8.6 percentage points to 66%.
Net profit doubled to SAR 95M (+106% YoY); operating cash flow increased to SAR 165M from SAR 72M.
Gross written premiums stable at SAR ~6.5B; EBITDA margin rose to 31.7%.
EPS nearly doubled to 1.29 from 0.65 year-over-year.
Outlook and guidance
Positioned for further growth with new product launches and ongoing M&A activities.
Continued focus on innovation, digital transformation, and expanding financial services distribution.
Latest events from Rasan
- FY 2025 saw 82% revenue growth and record profitability, with strong outlook for FY 2026.8313
Q4 202516 Mar 2026 - Net profit rose 140.7% on 21% revenue growth, with record margins and IPO proceeds boosting cash.8313
Q2 20249 Dec 2025 - Net profit up 53% on 29% revenue growth, driven by IPO and Tameeni segment strength.8313
Q3 20249 Dec 2025 - Record 83% revenue growth and 213% net profit surge, driven by digital and leasing segments.8313
Q3 20259 Dec 2025 - Revenue up 80% and net profit up 286% year-over-year, with strong segment and margin growth.8313
Q1 20259 Dec 2025 - H1 2025 revenue up 88% and adjusted net profit up 357%, with margins and segment growth strong.8313
Q2 20259 Dec 2025